XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 6 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Noked Israel Ltd | 198,888 | $483 | 0.13% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 5,584 | $13,232 | 0.00% |
| Citadel Advisors | 15,435 | $36,581 | 0.00% |
| MORGAN STANLEY | 33,151 | $80,557 | 0.00% |